The global POC platform & technology market was valued at US$ 21,370.3 Million in 2016 and is expected to exhibit a robust CAGR of 8.9% over the forecast period (2017 – 2025).
Vaccine manufacturers are focusing on partnering with organizations such WHO, UNICEF, and GAVI Alliance to improve their vaccination programs, in order to reach the maximum population to offer vaccine...
Patent expiration of branded products and drug resistance to antifungal medications are the factors restraining growth of the market.
North America is expected to be the dominant market in the global SLE treatment market, over the forecast period.
The global multiple sclerosis therapeutics market was valued at US$ 19.6 billion in 2016 and is expected to witness a robust CAGR of 2.5% over the forecast period (2017 - 2025).
The global radiotherapy market was valued at US$ 5,253.7 million in 2016 and is expected to witness a robust CAGR of 6.8% over the forecast period (2017 - 2025).
Adoption of these systems by various hospitals is expected to propel the growth of the Image guided therapy systems market
The global vascular closure devices market was valued at US$ 848.2 million in 2016 and is expected to witness a CAGR of 6.1% over the forecast period (2017 – 2025).
Increased need of palliative care and need for more surgical procedures to drive growth of the large volume parenteral market
The global patient positioning devices market was valued at US$ 985.4 million in 2017 and is expected to witness a robust CAGR of 4.2% over the forecast period (2017 - 2025).
The thrombocytopenia treatment market is driven by increasing prevalence of thrombocytopenia globally.
Effective treatment through minimally invasive catheter-based endovascular procedure to drive renal denervation devices market growth
Increase in investment in research and development for new medicines is accounting for the growth of novel drug delivery systems market in North America
Technological advancements in cardiac implant to drive the implantable medical devices market
Advanced approaches for the treatment of AID is expected favor the growth of autoimmune disease treatment market